openPR Logo
Press release

Efinaconazole Market Trends, Business Strategies and Opportunities With Key Players Analysis 2030

06-28-2022 08:23 AM CET | Health & Medicine

Press release from: Allied Analytics LLP

/ PR Agency: Allied Analytics LLP
Efinaconazole Market

Efinaconazole Market

According to a new report published by Allied Market Research, titled, "Efinaconazole Market: Global Opportunity Analysis and Industry Forecast, 2021-2030" Efinaconazole topical solution is used to treat fungal toenail infections (infections that may cause nail discoloration, splitting, or pain). Efinaconazole topical solution is in a class of medications called antifungals, which inhibit fungal lanosterol 14ฮฑ-demethylase involved in biosysnthesis of ergosterol, a constituent of fungal cell membranes. This medication treats only fungal infections. It does not work for other types of infections, such as those caused by bacteria. Moreover, this medication is used to treat onychomycosis of toenails (tinea unguium and ringworm of the nail) caused by Trichophyton rubrum or T. mentagrophytes. It works by stopping growth of certain types of fungus.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐จ๐ฎ๐œ๐ก๐ž๐ซ: https://www.alliedmarketresearch.com/request-sample/15279

COVID-19 Scenario Analysis:
The COVID-19 outbreak has transformed the national healthcare priorities and spending, however, it is considered to have short-term impact on the onychomycosis treatment market. Increase in number of COVID-19 patients around the world have led to increased focus on treatment of these patients on priority basis reduced patient visits to hospitals for diagnosis and treatment of onychomycosis or other nail and foot related fungal infections. Reduced visits indicate lesser treatment adoption, which has been affecting the market negatively. In addition, reduced visits to healthcare facilities to avoid cross contamination, which is another factor reducing sales. Moreover, onychomycosis generally is not given much importance as compared to other chronic diseases. Owing to reduced severity of the disease, the global efinaconazole market has experienced even lesser sales during the pandemic.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/15279

British Journal of Dermatology and International Journal of Dermatology shows that approximately 34% diabetic patients have onychomycosis and they are almost three times more likely to develop onychomycosis than non-diabetics. Hence, owing to these reasons, the global efinaconazole market may experience a significant amount of growth during the forecast period. Moreover, rise in inclination of consumers toward maintaining aesthetic appeal of their nails has been observed, and is one of the major factors driving the efinaconazole market.

๐Š๐ž๐ฒ ๐๐ž๐ง๐ž๐Ÿ๐ข๐ญ๐ฌ:
โ€ข This study presents the analytical depiction of the global efinaconazole market along with the current trends and future estimations to determine the imminent investment pockets.
โ€ข The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
โ€ข The current market is quantitatively analyzed from 2020 to 2030 to highlight the market growth scenario.
โ€ข Porter's five forces analysis illustrates the potency of buyers & suppliers in the market.
โ€ข The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/15279

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:
โ€ข Kaken Pharmaceutical Co. Ltd.
โ€ข Procos S.p.A.,
โ€ข Topharman CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD.,
โ€ข Taizhou Volsen Chemical Co. Ltd.,
โ€ข Valeant Pharmaceuticals International Inc.,
โ€ข Zhejiang Ausun Pharmaceutical Co. Ltd.,
โ€ข Tenova Pharmaceuticals Inc.,
โ€ข Viwit Pharmaceuticals Limited,
โ€ข RXN Chemicals Pvt. Ltd.

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Veterinary Imaging Market: https://www.alliedmarketresearch.com/veterinary-imaging-market

Veterinary Medicine Market: https://www.alliedmarketresearch.com/veterinary-medicine-market

Hydrocephalus Shunts Market: https://www.alliedmarketresearch.com/hydrocephalus-shunts-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Efinaconazole Market Trends, Business Strategies and Opportunities With Key Players Analysis 2030 here

News-ID: 2664426 • Views: โ€ฆ

More Releases from Allied Analytics LLP

Heat Meters Market Set to Grow with Rising Demand for Energy Efficiency
Heat Meters Market Set to Grow with Rising Demand for Energy Efficiency
According to a new report published by Allied Market Research, the heat meters market size was valued at $1.6 billion in 2022, and is estimated to reach $2.7 billion by 2032, growing at a CAGR of 5.4% from 2023 to 2032. A heat meter is a device used to measure and quantify the amount of thermal energy (heat) transferred from a heat source to a system or consumer. It accurately measuresโ€ฆ
Heat Pump Market Set for Strong Growth Through 2032
Heat Pump Market Set for Strong Growth Through 2032
According to a new report published by Allied Market Research, the heat pump market size was valued at $71.2 billion in 2022, and is estimated to reach $201.5 billion by 2032, growing at a CAGR of 11.1% from 2023 to 2032. A heat pump is a versatile and efficient device that transfers heat from one location to another using a refrigeration cycle. It operates by absorbing heat from a low-temperature sourceโ€ฆ
Energy Efficient Lighting Market Shines Bright with Strong Growth Outlook
Energy Efficient Lighting Market Shines Bright with Strong Growth Outlook
According to a new report published by Allied Market Research, the global energy efficient lighting market was valued at $46.2 billion in 2021 and is projected to reach $93.3 billion by 2030, growing at a robust CAGR of 8.1% from 2022 to 2030. This surge reflects a powerful global movement toward greener, smarter, and more cost-effective lighting technologies. Energy efficient lighting refers to lighting systems and products that use less electricityโ€ฆ
The Future of Energy: How Fuel Cells Are Reshaping Power Generation
The Future of Energy: How Fuel Cells Are Reshaping Power Generation
According to a new report published by Allied Market Research, titled, "Fuel Cell Market," The fuel cell market size was valued at $3.6 billion in 2020, and is estimated to reach $32.0 billion by 2030, growing at a CAGR of 19.4% from 2021 to 2030. The fuel cell market has emerged as a transformative force in the global energy landscape, offering a clean, efficient, and sustainable alternative to conventional energy sources.โ€ฆ

All 5 Releases


More Releases for Efinaconazole

Oncychomycosis Treatment Market Size in 7MM is expected to grow at a decent CAGR โ€ฆ
DelveInsight's "Oncychomycosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Oncychomycosis, historical and forecasted epidemiology as well as the Oncychomycosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover Key Insights into the Oncychomycosis Market with DelveInsight's In-Depth Report @ Oncychomycosis Market Size- https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Oncychomycosis Market Report โ€ข The total prevalent cases of Onychomycosis in theโ€ฆ
Onychomycosis Market Size in the US was ~USD 760 million in 2023, is expected to โ€ฆ
DelveInsight's "Oncychomycosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Oncychomycosis, historical and forecasted epidemiology as well as the Oncychomycosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover Key Insights into the Oncychomycosis Market with DelveInsight's In-Depth Report @ Oncychomycosis Market Size [https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr] Key Takeaways from the Oncychomycosis Market Report * The total prevalent cases of Onychomycosis inโ€ฆ
Dermatophytic Onychomycosis Treatment Industry Analysis: 7.8% CAGR Growth and Ma โ€ฆ
The dermatophytic onychomycosis treatment market has been witnessing significant growth, driven by an increase in the prevalence of fungal nail infections and a growing geriatric population. The market was valued at USD 4.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2034, reaching USD 11.2 billion by the end of the forecast period. This article delves into the factorsโ€ฆ
Onychomycosis Market Dynamics, Growth Drivers, Market Constraints and Challenges โ€ฆ
According to Precision Business Insights (PBI), the latest report, the onychomycosis market was valued at USD 4,206.8 million in 2023 and is expected to grow at a 3.8% CAGR from 2024 to 2029. Increasing diagnosis of fungal nail infections has raised awareness of fungal infections of the nails. In addition, increasing awareness of onychomycosis among podiatrists and dermatologists has led to an increase in demand for effective medications. The aboveโ€ฆ
Onychomycosis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest โ€ฆ
DelveInsight's "Onychomycosis Market Insights, Epidemiology, and Market Forecast-2032โ€ณ report offers an in-depth understanding of the Onychomycosis, historical and forecasted epidemiology as well as the Onychomycosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Onychomycosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Onychomycosis Market Forecast Some of the key facts of the Onychomycosisโ€ฆ
Efinaconazole Market to Perceive Substantial Growth during 2020-2025 | Estimated โ€ฆ
This report provides in depth study of "Efinaconazole Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Smart Home as a Service Market report also provides an in-depth survey of key players in the market organization. Global Efinaconazole Market overview: BusinessIndustryReports have new report spread across 96 pages is an overview of the Global Efinaconazole Market Report 2020. The Global Efinaconazole Market is projected to grow atโ€ฆ